Stocktoria

EXELIXIS, INC. EXEL

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-04-11 · LEI

EXELIXIS, INC. statistics & valuation

Market cap$13.8B
P / E17.6×
P / S5.9×
P / B6.4×
P / FCF15.7×
Net margin33.7%
Return on equity36.2%
FCF margin37.7%
Return on capital35.8%
Graham number -56.5%$21.90

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($21.90); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-36.70% 34.10% 80.80% 33.20% 11.30% 16.10% 11.30% 11.40% 24.00% 33.70% 2016201720182020202120212022202320252026
Gross margin (%)
2016201720182020202120212022202320252026
Operating margin (%)
-14.70% 36.70% 51.40% 38.20% 11.10% 20.00% 12.50% 9.30% 27.90% 37.60% 2016201720182020202120212022202320252026
Return on equity (%)
-78.60% 54.10% 53.60% 19.00% 5.90% 10.50% 7.30% 9.20% 23.20% 36.20% 2016201720182020202120212022202320252026
Shares outstanding
289.9M 312.0M 312.8M 315.0M 318.0M 322.4M 324.6M 321.5M 296.1M 281.9M 2016201720182020202120212022202320252026
Net debt ($)
$37.4M -$183.2M 2016201720182020202120212022202320252026
Share buybacks ($)
2016201720182020202120212022202320252026
Return on assets (%)
-11.80% 23.50% 48.50% 17.00% 5.20% 8.80% 5.90% 7.10% 17.70% 27.50% 2016201720182020202120212022202320252026
Free cash flow margin (%)
106.90% 31.90% 44.80% 53.10% 18.10% 24.20% 20.80% 16.00% 31.00% 37.70% 2016201720182020202120212022202320252026
Debt / equity (×)
2.12× 0.00× 2016201720182020202120212022202320252026
EPS ($)
$0.49 $2.21 $1.02 $0.35 $0.72 $0.56 $0.65 $1.76 $2.78 2016201720182020202120212022202320252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

EXELIXIS, INC. trades at about 18.1× earnings — below its 10-year norm (10-year range 9.2×–63.5×, median 25.1×).

9.2× 63.5×

Shaded band = 10-year range (9.2×–63.5×); dot = today's 18.1×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2025FY2023FY2022FY2021FY2021FY2020FY2018FY2017FY2016
Operating margin37.6%27.9%9.3%12.5%20.0%11.1%38.2%51.4%36.7%-14.7%
Net margin33.7%24.0%11.4%11.3%16.1%11.3%33.2%80.8%34.1%-36.7%
FCF margin37.7%31.0%16.0%20.8%24.2%18.1%53.1%44.8%31.9%106.9%
Return on assets27.5%17.7%7.1%5.9%8.8%5.2%17.0%48.5%23.5%-11.8%
Return on equity36.2%23.2%9.2%7.3%10.5%5.9%19.0%53.6%54.1%-78.6%
Debt / equity————————0.00×2.12×
Current ratio3.563.633.344.995.437.067.088.504.211.74

Computed from company filings · US · as of 2026-01-02. Facts plus Stocktoria's own computed scores — not investment advice.